Anatomical evidence indicates that medial prefrontal cortex (mPFC) neurons project to the dorsal raphe nucleus (DR). In this study, we functionally characterized this descending pathway in rat brain. Projection neurons in the mPFC were identified by antidromic stimulation from the DR. Electrical stimulation of the mPFC mainly inhibited the activity of DR 5-HT neurons (55 of 66). Peristimulus time histograms showed a silence of 150 Ϯ 9 msec poststimulus (latency, 36 Ϯ 1 msec). The administration of WAY-100635 and picrotoxinin partly reversed this inhibition, indicating the involvement of 5-HT 1A and GABA A receptors. In rats depleted of 5-HT with p-chlorophenylalanine, the electrical stimulation of mPFC mainly activated 5-HT neurons (31 of 40). The excitations (latency, 17 Ϯ 1 msec) were antagonized by MK-801 and NBQX. Likewise, MK-801 prevented the rise in DR 5-HT release induced by electrical stimulation of mPFC. The application of 8-OH-DPAT in mPFC significantly inhibited the firing rate of DR 5-HT neurons and, in dual-probe microdialysis experiments, reduced the 5-HT output in mPFC and DR. Furthermore, the application of WAY-100635 in mPFC significantly antagonized the reduction of 5-HT release produced by systemic 8-OH-DPAT administration in both areas. These results indicate the existence of a complex regulation of DR 5-HT neurons by mPFC afferents. The stimulus-induced excitation of some 5-HT neurons by descending excitatory fibers releases 5-HT, which inhibits the same or other DR neurons by acting on 5-HT 1A autoreceptors. Afferents from the mPFC also inhibit 5-HT neurons through the activation of GABAergic interneurons. Ascending serotonergic pathways may control the activity of this descending pathway by acting on postsynaptic 5-HT 1A receptors.
Serotonergic [5-hydroxytryptamine (5-HT)] neurons participate in many physiological functions and are the cellular target of drugs used to treat psychiatric illnesses Jacobs and Azmitia, 1992; Montgomery, 1994; Meltzer, 1999) . Their activity is controlled by 5-HT 1A autoreceptors in the raphe nuclei (Blier and de Montigny, 1987; Sprouse and Aghajanian, 1987) . Also, afferents to the dorsal raphe nucleus (DR) originate in various brain areas. These include the catecholamine groups (Baraban and Aghajanian, 1980; Peyron et al., 1995 Peyron et al., , 1996 , the lateral habenula Stern et al., 1981; Kalén and Wiklund, 1989) , the hypothalamus (Peyron et al., 1998) , the substantia nigra (Stern et al., 1981) , and the medial prefrontal cortex (mPFC) Sesack et al., 1989; Takagishi and Chiba, 1991; Hajós et al., 1998; Peyron et al., 1998) .
Pyramidal neurons of the mPFC integrate cortical and thalamic inputs and project mainly to subcortical areas, including, among others, the mediodorsal nucleus of the thalamus, the amygdaloid complex, the lateral habenula, hypothalamic areas, and the brainstem aminergic nuclei Thierry et al., 1983; Sesack et al., 1989; Sesack and Pickel, 1992; Murase et al., 1993; Hajós et al., 1998; Peyron et al., 1998) . In turn, the mPFC is densely innervated by aminergic fibers from the latter nuclei. In particular, it receives serotonergic afferents from the raphe nuclei (Azmitia and Segal, 1978) and contains a large density of various 5-HT receptors (see below). Given its unique cytoarchitecture and connectivity, the prefrontal cortex regulates a large number of cognitive and associative functions and is involved in the planning and execution of complex tasks (Fuster, 1997) . Severe mental illnesses have been associated with an abnormal prefrontal function (Andreasen et al., 1997; Drevets et al., 1997) . Given the involvement of 5-HT in psychiatric diseases such as anxiety, depression, and schizophrenia, the relationships between the mPFC and 5-HT neurons are of particular importance to understand the pathophysiology and treatment of these diseases. Layer V pyramidal neurons in mPFC are enriched in 5-HT 1A and 5-HT 2A receptors (Pazos and Palacios, 1985; Pompeiano et al., 1992 Pompeiano et al., , 1994 Kia et al., 1996) with opposed effects on neuronal excitability (Araneda and Andrade, 1991) . The activation of pyramidal 5-HT 2A receptors triggers an increase in EPSCs, resulting from an enhanced glutamate release and subsequent activation of AMPA-KA receptors (Aghajanian and Marek, 2000) . Likewise, the local activation of 5-HT 2A and 5-HT 1A receptors increases and decreases, respectively, the 5-HT release in mPFC (Casanovas et al., 1999; Martín-Ruiz et al., 2001) . Because of the existence of descending projections from the mPFC to the DR, postsynaptic 5-HT receptors in mPFC could exert a distal feedback via descending inputs. Indeed, there is circumstantial evidence supporting that postsynaptic 5-HT 1A receptors participate in the control of serotonergic activity (Blier and de Montigny, 1987; Ceci et al., 1994; Romero et al., 1994; Hajós et al., 1999) . In the present study we examine the control of the activity of DR 5-HT neurons by the mPFC and the transmitters and receptors involved in this control.
MATERIALS AND METHODS Animals
Male Wistar rats weighing 260 -320 gm (Iffa Credo, Lyon, France) were used. Animal care followed the European Union regulations (EEC Council Directives of 24/11/1986; 86/609/ EEC). They were kept in a controlled environment (12 hr light /dark cycle and 22 Ϯ 2°C room temperature). Food and water were provided ad libitum before and during microdialysis experiments, which usually began between 9:00 and 10:00 A.M. The stereotaxic coordinates (in millimeters) were taken from the atlas of Paxinos and Watson (1986) using bregma and dura mater as references.
Chemicals 5-HT oxalate, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), (ϩ)M K-801 (dizolcipine), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f) quinoxaline (N BQX), picrotoxininin, -1-piperazinyl)ethyl)-N-(2-pyridyl) cyclohexanecarboxamide ⅐ 3HC l (WAY-100635) were from Sigma (St. L ouis, MO) and Research Biochemicals (Natick, M A). C italopram ⅐ HBr was from L undbeck A /S. Other materials and reagents were from local commercial sources.
Single-unit extracellular recordings
These were performed as previously described (Saw yer et al., 1985; C elada et al., 1996) . For recording experiments, rats were anesthetized with chloral hydrate (400 mg / kg, i.p.). The femoral vein was cannulated for the administration of drugs, and additional anesthetic (chloral hydrate, 80 mg / kg) was regularly given to maintain anesthesia. Rats were placed in a David Kopf (T ujinga, CA) stereotaxic frame. All wound margins and points of contact between the animal and the stereotaxic apparatus were infiltrated with lidocaine solution (5%). Body temperature was maintained at 37 Ϯ 1°C with a heating pad. The atlanto-occipital membrane was punctured to allow some drainage of the C SF. After scalp removal, two small burr holes were drilled over the mPFC [anteroposterior (AP) ϩ3.4 from bregma, lateral (L) Ϯ0.5] for the insertion of stimulating electrodes. A 4 ϫ 4 mm recording hole was drilled over lambda, and the saggital sinus was ligated, cut, and reflected. Bipolar stimulating electrodes consisted of two stainless steel enamel-coated wires (C alifornia Fine Wire, Grover Beach, CA) with a diameter of 150 m and a tip separation of ϳ100 m and in vitro impedances of 10 -30 K⍀. Electrodes were lowered to 5 mm below the cortical surface and cemented in place with cyanoacrylate glue and dental cement. For the antidromic identification of pyramidal neurons projecting to the DR, a recording hole was drilled over the mPFC, and the stimulating electrode was implanted in the DR [AP Ϫ7.8 from bregma, L Ϫ3.1, dorsoventral (DV) Ϫ6.8, with an angle of 30°]. The antidromic nature of DR-evoked responses was determined by collision extinction with spontaneously occurring spikes (Fuller and Schlag, 1976) . Recording electrodes were made from 2.0 mm outer diameter (o.d.) capillary glass (W PI, Saratosa, FL) pulled on a Narishige (Tokyo, Japan) PE-2 pipette puller and filled with 2 M NaC l. The electrode impedance was lowered to 4 -10 M⍀ by passing 500 msec 150 V DC pulses (Grass stimulation model S-48) through the electrode.
Constant current electrical stimuli were generated with a Grass stimulation unit S-48 connected to a Grass SI U 5 stimulus isolation unit. mPFC neurons were stimulated with monophasic square wave pulses (0.2 msec, 0.9 Hz, 0.5-2.5 mA). Single-unit extracellular recordings were amplified with a Neurodata IR283 (C ygnus Technology, Delaware Water Gap, PA), postamplified, and filtered with a C ibertec (Madrid, Spain) amplifier, and computed on-line using a DAT 1401plus interface system Spike2 software (C ambridge Electronic Design, C ambridge, UK). Data were also recorded on magnetic audiotape for off-line recording if necessary. Descents were performed along the midline. 5-HT neurons were usually encountered 4.8 -6.5 mm below the brain surface and identified according to previously described electrophysiological criteria . Serotonergic neurons exhibited a regular firing rate with frequencies of 0.4 -3.5 Hz, and 2-5 msec biphasic or triphasic extracellular waveforms and were inhibited by the 5-HT 1A agonist 8-OH-DPAT.
Surgery and microdialysis procedures
Microdialysis procedures in unanesthetized rats were performed essentially as described in Adell and Artigas (1991) . Anesthetized rats (pentobarbitone, 60 mg / kg, i.p.) were placed in a stereotaxic apparatus and implanted with microdialysis probes. Dual probe microdialysis was performed by implanting two I-shaped probes in the mPFC (AP ϩ3.4, L Ϫ0.8, DV Ϫ6.0) and the DR (AP Ϫ7.8, L Ϫ3.1, DV Ϫ7.5). Probes in the DR were implanted with an angle of 30°to avoid obstruction of the cerebral aqueduct. The length of membrane exposed to the brain tissue was 4 mm long (o.d. 0.25 mm) in mPFC and 1.5 mm long in DR. One group of rats was implanted with 4 mm probes in the lateral prefrontal cortex (AP ϩ3.4, L Ϫ3.0, DV Ϫ6.0) and DR (as above) to control for the effects in DR of the local application of 8-OH-DPAT in mPFC.
Animals were allowed to recover from surgery for ϳ20 hr, and then probes were perf used with artificial C SF (aC SF) (in mM: 125 NaC l, 2.5 KC l, 1.26 C aC l 2, and 1.18 MgC l 2 ) containing 1 M citalopram at 0.25 l /min. Sample collection started 60 min after the beginning of perf usion. Dialysate samples were collected every 20 min (5 l). Usually five or six fractions were collected before drug administration, of which four were used to obtain the individual basal values. T wo different microdialysis experiments were conducted in unanesthetized rats. In the first one, groups of rats were administered with two sequential injections of 8-OH-DPAT (0.1 ϩ 0.1 mg / kg, s.c.) 3 hr apart. Animals of the control group received the two injections in identical conditions, and the effects of 8-OH-DPAT on 5-HT release were examined in the DR and mPFC (rats had dual implants). T wo other groups of rats received the first 8-OH-DPAT injection in control conditions, and the second one was administered while the 5-HT 1A receptor antagonist WAY-100635 (100 M) was perf used into the DR or the mPFC (perf usions began 40 min before the second 8-OH-DPAT injection) to examine the role of presynaptic and postsynaptic 5-HT 1A receptors in the control of 5-HT release in both areas. The ratios between the inhibitions of the second and first injection on 5-HT release were calculated and compared in both groups (i.e., with and without WAY-100635 in the DR or mPFC).
In another experiment, 8-OH-DPAT (100 and 300 M; 120 min each) was perf used through the probe in mPFC, and 5-HT was analyzed in dialysates from the mPFC and DR of the same animals (dual implants). The total amount of 8-OH-DPAT perf used through the dialysis probes at the two concentrations used was 3 and 9 nmol over the course of 2 hr (uncorrected for probe recovery). T wo groups of controls were used, one receiving aC SF in both sites for the entire collection period (sham changes of perf usion syringes were also performed in this group) and another one in which the prefrontal probes were placed more laterally, in an area devoid of neurons projecting to the DR (Peyron et al., 1998 ; see above coordinates).
Electrical stimulation and microdialysis in anesthetized rats
We examined the effect of the electrical stimulation of the mPFC on the 5-HT release in the DR. Microdialysis probes were implanted the day before, as above. After chloral hydrate anesthesia, rats were placed in the stereotaxic frame, and stimulating electrodes were placed in the mPFC. In a first experiment, the effects of three different stimulation conditions (S1-S3) were examined: S1, 0.9 Hz, 1.7 mA, 0.2 msec; S2, 10 Hz, 0.5 mA, 1 msec; S3, 20 Hz, 0.5 mA, 1 msec. A second experiment assessed the effects of S4 (0.9 Hz, 2 mA, 0.2 msec) and S3. Both S1 and S4 mimicked the stimulation conditions at which peristimulus time histograms (PSTHs) were obtained, whereas S2 and S3 were chosen to examine the effects of higher frequency stimulation (10 -20 Hz) at a lower intensity (0.5 mA). Dialysate fractions were collected every 10 min. In these experiments, perf usion rate was 1.5 l /min to facilitate the handling of the dialysate samples. Probes were perf used with aC SF containing 1 M citalopram as above. Usually 10 fractions were collected before electrical stimulation.
Chromatographic analysis
5-HT was determined using a modification of an HPLC method previously described (Adell and Artigas, 1998) . The composition of the chromatographic eluant was as follows: 0.15 M NaH 2 PO 4 , 1.3 mM octyl sodium sulfate, and 0.2 mM EDTA, pH 2.8 adjusted with phosphoric acid, plus 27% methanol. 5-HT was separated on a 3 m ODS 2 column (7.5 cm ϫ 0.46 cm; Beckman, San Ramón, CA) and detected amperometrically with a Hewlett Packard 1049 detector (oxidation potential, ϩ0.6 V). Retention time was 3.5-4 min. The absolute detection limit for 5-HT was typically 1 fmol /sample. Dialysate 5-HT values were calculated by reference to standard curves run daily.
Drug administration
Local administration. In electrophysiological experiments, drugs (dissolved in aC SF) were inf used through a 32 gm stainless steel cannula (Small Parts Inc., Miami, FL) implanted in the mPFC (same coordinate as stimulating electrodes). The cannula was attached to a 10 l Hamilton syringe by a Teflon tubing. A microinf usion pump (Bioanalytical Systems Inc., West Lafayette, I N) was used. After recording baseline spontaneous activity, 200 nl of the 5-HT 1A agonist 8-OH DPAT (100 M; Research Biochemicals) was inf used over the course of 1 min. This volume has been reported to diff use to a maximum effective diameter of 0.4 -0.6 mm (Myers, 1971) .
In dialysis experiments the local application of 8-OH-DPAT (100 and 300 M) and WAY-100635 (100 M) dissolved in aC SF was made by reverse dialysis through the probe. We examined the extent of the diff usion of WAY-100635 in the DR after its local application by using [
3 H]WAY-100635 (Amersham Pharmacia Biotech, Little Chalfont, UK), as described (Romero and Artigas, 1997) . We used the DR to examine drug diff usion because of the concentration of 5-HT 1A receptors in a small brain area. Four rats were implanted with 1.5-mm-long probes in the DR, which were perf used at 0.25 l /min with aC SF containing 100 M WAY-100635, plus 100 nM of the radioactive tracer. The in vitro recovery of the dialysis probes (1.5 mm) for WAY-100635 was 58.7 Ϯ 4.6% (as measured by the amount of tritium label of the tracer). After an inf usion period of 80 min, the rats were decapitated, and the brains were removed and frozen. Coronal midbrain sections (14-m-thick) were cut to examine the labeling of 5-HT 1A receptors in the DR by [
3 H] WAY-100635 (Gozlan et al., 1995; K hawaja et al., 1995) . Given the rostrocaudal distribution of the various neuronal groups composing the DR, coronal sections were cut at different anteroposterior levels (approximately from Ϫ6.5 to Ϫ9.0 mm relative to bregma). Additional sections were cut in some rats at hippocampal and cortical levels. The sections were exposed to a tritium-sensitive film (Hyperfilm 3 H; Amersham) for 3 weeks. The optical density of the tritium labeling in films was measured using an image analysis system (Imaging Research Inc., St. C atharines, Ontario, C anada). The surface of areas showing a dense labeling by [ 3 H]WAY-100635 was quantified to calculate the total amount of tritium label in each section and the density of ligand binding.
Systemic administration. The 5-HT synthesis inhibitor p-clorophenylalanine ( pC PA) was dissolved in saline and administered (350 mg / kg, i.p.) 48 and 24 hr before the recordings. At the end of the experiments, a portion of the frontoparietal cortex was dissected out, weighed, and frozen at Ϫ80°C for subsequent analysis of 5-HT.
In some electrophysiological experiments, once a stable response to mPFC stimulation was obtained, we administered intravenously the selective 5-HT 1A receptor antagonist WAY-100635 (5-10 g / kg, i.v.), the GABA A receptor antagonist picrotoxinin (1-2 mg / kg, i.v.; Sigma), the NMDA receptor antagonist (ϩ)M K-801 (0.66 -0.99 mg / kg, i.v.; RBI); or the AM PA-kainate glutamate antagonist N BQX (1-2 mg / kg, i.v.; Tocris Cookson, Bristol, UK) to examine their effects on the response of DR 5-HT neurons to the mPFC stimulation. T ypically, drug effects were measured starting 1.5-4 min after administration. In microdialysis experiments, 8-OH-DPAT was administered subcutaneously at 0.1 mg / kg.
Histology
At the end of the experiments, rats were killed by an overdose of anesthetic. Rats used in electrophysiology experiments were perf used transcardially with saline followed by 10% formalin solution (Sigma). Brains were post-fixed, sectioned (70 m), and stained with Neutral Red for histological verification of stimulating and inf usion cannula sites. In microdialysis experiments the placement of the dialysis probes was checked by perf using Fast Green dye and visual inspection of the probe track after cutting the brain at the appropriate levels.
Data treatment and statistical analyses
Responses in 5-HT neurons evoked by mPFC stimulation were characterized by measuring the magnitude and duration of inhibitory and excitatory responses from PSTHs following essentially the criteria described by Hajós et al. (1998) . The following responses were identified: (1) antidromic activation: antidromic spikes following a constant latency. The antidromic nature of this excitation was determined by collision extinction with spontaneously occurring spikes (Fuller and Schlag, 1976) . (2) Orthodromic activation: orthodromic excitations elicited spikes with short and variable latencies. In orthodromically activated neurons, the cortical stimulation evoked orthodromic spikes with a success rate higher than 10%. Milder activations (5-10%) were also observed in a substantial number of neurons, mostly followed by inhibitory responses. (3) Inhibitions: The onset of the inhibition was defined by either a total cessation of spikes for at least four successive bins (10 msec width) or a 75% decrease in the number of spikes with respect to the prestimulus value. The offset of the inhibition was defined as the first of four bins equal to or above the prestimulus value.
The changes in firing rate after 8-OH-DPAT administration in mPFC were quantified by analyzing a 2 min epoch centered around the maximal changes produced by drug inf usion and comparing them to a similar 2 min epoch before the onset of drug inf usion in mPFC. The effects of drugs were assessed using one-way repeated measures ANOVA and paired Student's t test.
Microdialysis results were expressed as femtomoles per fraction and represented in the figures as percentages of baseline. ANOVA for repeated measures of raw data were used to assess the effects of drug administration or electrical stimulation on 5-HT release. In the experiments involving two sequential injections of 8-OH-DPAT, we computed the individual ratios between the value of 5-HT in the two fractions (7 and 16) at which the effect of 8-OH-DPAT was maximal (peak ratios). These values were used to examine the effects of the application of WAY-100635 (in DR or mPFC) on the effects of the second 8-OH-DPAT injection.
Statistical significance has been set at the 95% confidence level (twotailed). Unless otherwise specified, all values are expressed as the mean Ϯ SEM.
RESULTS

Identification of mPFC neurons projecting to the DR
In an initial experiment, we identified by antidromic activation pyramidal mPFC neurons projecting to the DR (mPFC recordings were performed at the same coordinate used for stimulation experiments; see below) ( Fig. 1) . Seventeen neurons were antidromically activated from the DR with a latency 17.6 Ϯ 1.6 msec. Considering an average linear distance of 11.1 mm between the stimulation and recording sites, the conduction velocity (distance/ latency) was 0.63 m/sec, in the range of reported values for mPFC efferent fibers (Thierry et al., 1983) .
Effect of mPFC stimulation on DR 5-HT neurons
The effect of the electrical stimulation of the mPFC was studied on 106 5-HT neurons in the DR responding to the stimulation (Table 1) . Two main types of responses were recorded: inhibition and orthodromic activation. Neurons that were antidromically activated were not considered. The majority of the recorded 5-HT neurons in control rats (55 of 66; 83%) responded to mPFC stimulation (currents ranging from 0.5 to 2.5 mA) with a shortlatency poststimulus inhibition (Fig. 2 A) . Of these, 18 showed a concurrent short-latency subthreshold (5-10%) orthodromic activation (Fig. 2 B) . Eleven (of 66) neurons (17%) responded to mPFC stimulation with a short-latency orthodromic activation (Ͼ10%) (Fig. 2C,D) . The success rate of orthodromic activation varied between neurons and was 24.7 Ϯ 7.7% on average (n ϭ 11).
We assessed the effects of the electrical stimulation of the mPFC on the 5-HT release in the DR of chloral hydrateanesthetized rats (Fig. 3) . Control rats were implanted with electrodes in the mPFC but received no stimulation. Dialysate fractions were collected every 10 min. Two different experiments were performed. In the first (pilot) experiment, electrical stimulation was delivered in three different conditions (S1-S3; see legend to Fig. 3 ) for two fractions (20 min total), separated from each other by 10 min. The electrical stimulation of the mPFC enhanced 5-HT release in the DR, to a maximum of 156 Ϯ 21% of baseline at the third stimulation (Fig. 3A) . Two-way ANOVA analysis revealed a significant effect of the time ( p Ͻ 0.00001) and of the time ϫ group interaction ( p Ͻ 0.00001) versus controls. In a second experiment, a first stimulation period was delivered for 20 min (S4, 0.9 Hz, 0.2 msec, 2 mA) followed by a second stimulation (S3, 20 Hz, 1 msec, 0.5 mA) for 20 min delivered 40 min later. As in the first experiment, the electrical stimulation of the mPFC increased the 5-HT release in the DR compared with sham-stimulated rats (Fig. 3B) . Two-way ANOVA revealed a significant effect of the time ( p Ͻ 0.02) and of the time ϫ group interaction ( p Ͻ 0.0005). Interestingly, the stimulation of the mPFC using S4 stimulation conditions produced a transient elevation of the 5-HT release in the DR, whereas the stimulation at a higher frequency (20 Hz) and lower intensity (0.5 mA) (S3 conditions) resulted in an increase in 5-HT that persisted 40 min after the end of the stimulation period (Fig. 3B) .
Role of 5-HT 1A autoreceptors on the mPFC-induced inhibitions
The above results suggested that the stimulation of mPFC excited a proportion of DR 5-HT neurons. These could release 5-HT which, by acting on local 5-HT 1A receptors, would inhibit the same or other 5-HT neurons in the DR. To examine this possibility we used two different experimental approaches. In the first one, rats were administered the selective 5-HT 1A receptor antagonist WAY-100635 once a basal PSTH was recorded (typically, 250 sweeps). The administration of WAY-100635 (5-10 g/kg, i.v.) significantly reduced the percentage of basal inhibition (13 Ϯ 2 to 65 Ϯ 10% of prestimulus firing rate; p Ͻ 0.001; paired t test; n ϭ 11) and its duration (from 188 Ϯ 19 to 124 Ϯ 16 msec; p Ͻ 0.002; paired t test; n ϭ 11) without significantly altering the firing rate. Figure 4 shows two PSTHs of a 5-HT neuron in the DR, before ( A) and after ( B) the administration of WAY-100635 (5 g/kg, i.v.).
The contribution of 5-HT released in the DR after mPFC stimulation to the observed inhibitions was studied by pretreating the rats with the 5-HT synthesis inhibitor pCPA. In 5-HTdepleted rats ( pCPA; 2 ϫ 350 mg/kg, i.p.; 48 and 24 hr before experiments), the concentration of 5-HT in frontoparietal cortex was around 10% of that in control rats (30 Ϯ 3 pmol/gm; n ϭ 19 vs 288 Ϯ 37 pmol/gm; n ϭ 7; p Ͻ 0.0001; Student's t test). In pCPA-pretreated rats, the electrical stimulation of the mPFC resulted in a significantly higher proportion of orthodromic activations compared with control rats [77 (31 of 40) versus 17% (11 of 66) in control rats; p Ͻ 0.01;
2 test] (Table 1) . Nine neurons were equally inhibited by mPFC stimulation in pCPA-pretreated rats. The lower firing rate in pCPA-treated rats (Table 1) perhaps results from a reduction of noradrenergic synthesis (Reader et al., 1986) and reduced activation of ␣ 1 -adrenoceptors controlling 5-HT activity (Baraban and Aghajanian, 1980) . The electrical stimulation of the mPFC (20 Hz, 1 msec, 0.5 mA) did not change the firing rate of 5-HT neurons in control rats (baseline, 1.50 Ϯ 0.14 Hz; post-stimulation, 1.55 Ϯ 0.14 Hz; n ϭ 11; measured 4 min after the end of the stimulation period). However, it increased that in pCPA-treated rats, from 0.64 Ϯ 0.16 Hz (baseline) to 1.18 Ϯ 0.18 Hz (post-stimulation; also measured 4 min after the end of the stimulation period) ( p Ͻ 0.02; paired t test; n ϭ 7) (Fig. 5) .
Involvement of GABA A receptors in the mPFCtriggered inhibition of DR 5-HT neurons
Because neither 5-HT depletion nor 5-HT 1A receptor blockade totally reversed the mPFC-induced inhibition of 5-HT neurons, we assessed the involvement of GABA A receptors. The intravenous administration of picrotoxinin (1-2 mg/kg, i.v.) partially blocked the inhibitory responses to mPFC stimulation as shown in Figure 6 . Under basal conditions mPFC stimulation depressed firing rate to 11 Ϯ 3% of prestimulus baseline levels. The administration of picrotoxinin (1 mg/kg, i.v.) resulted in a significant reduction of the inhibition to 32 Ϯ 7% of prestimulus firing rate ( p Ͻ 0.005; paired t test; n ϭ 8). Likewise, the administration of picrotoxinin significantly reduced the duration of the mPFCtriggered inhibition (from 151 Ϯ 31 msec in baseline conditions to 124 Ϯ 26 msec; p Ͻ 0.02; paired t test; n ϭ 8) without altering the firing rate of the recorded neurons. The administration of an additional dose of picrotoxinin (1 ϩ 1 mg/kg, i.v.) further decreased the inhibition to 49 Ϯ 8% of prestimulus firing rate (paired t test; p Ͻ 0.05; n ϭ 5). The treatment with this additional dose of picrotoxinin significantly increased the firing rate from 0.9 Ϯ 0.3 to 1.8 Ϯ 0.2 spikes/sec ( p Ͻ 0.002; paired t test; n ϭ 5).
Ionotropic glutamate receptors and orthodromic activation of DR 5-HT neurons
We assessed the involvement of ionotropic glutamate receptors in the mPFC-induced orthodromic activations of 5-HT neurons. Because the percentage of neurons activated was higher in rats depleted of 5-HT (Table 1) , these experiments were performed in rats pretreated with pCPA (2 ϫ 350 mg/kg, as above). The treatment with the NMDA receptor antagonist MK-801 (0.66 -0.99 mg/kg, i.v.) markedly reduced the mPFC-induced orthodromic activation, from 40 Ϯ 11 to 10 Ϯ 4% ( p Ͻ 0.05; paired Student's t test; n ϭ 5). Figure 7 , B and C, shows the effect of MK-801 administration on the orthodromic activation of a representative DR 5-HT neuron.
To examine the involvement of local NMDA receptors on the mPFC-induced increase of 5-HT release in the DR, we performed an additional microdialysis experiment in chloral hydrateanesthetized rats. In these, the NMDA receptor antagonist MK-801 (300 M) was locally administered by reverse dialysis through the probe in the DR for 2 hr, beginning 1 hr before the mPFC stimulation (n ϭ 7). In this condition, the delivery of electrical stimuli in the mPFC (20 min, 20 Hz, 1 msec, 0.5 mA) did not enhance the 5-HT release in the DR (Fig. 3B) . The administration of the AMPA-KA antagonist NBQX (1 ϩ 1 mg/kg, i.v.) also reduced significantly the effect of the mPFC stimulation on the orthodromic activation of DR 5-HT neurons, from 29 Ϯ 6 to 11 Ϯ 3% ( p Ͻ 0.01; paired t test; n ϭ 5) (Fig.  7E,F ) .
Control of the 5-HT release in mPFC and DR by 5-HT 1A receptors in both areas
Systemic administration of 8-OH-DPAT
The basal 5-HT concentrations in the DR and mPFC in presence of 1 M citalopram were 66 Ϯ 13 fmol/fraction (n ϭ 19) and 16 Ϯ 1 fmol/fraction (n ϭ 20), respectively.
The administration of 8-OH-DPAT (0.1 mg/kg, s.c.) reduced the dialysate 5-HT concentration to 17.4 Ϯ 2.1% of baseline in mPFC and to 36.7 Ϯ 4.9% in the DR of the same rats. The 5-HT reduction was significantly more marked in mPFC than in DR ( p Ͻ 0.003; Student's t test). In both areas, a second injection of 8-OH-DPAT reduced 5-HT to an extent similar to that of the first injection. The peak ratios (fraction 7/fraction 16) were close to unity (119 Ϯ 12% in the DR, 101 Ϯ 11 in mPFC; n ϭ 6) (Fig. 8) .
The local application of 100 M WAY-100635 in the DR or mPFC did not enhance the basal 5-HT release in neither area but partly prevented the reduction of 5-HT release elicited by the second 8-OH-DPAT injection in the DR and mPFC. Figure 8 shows the peak ratios for the groups of rats treated with 8-OH-DPAT (0.1 mg/kg, s.c.) in the control situation (both injections given in identical conditions) and when WAY-100635 was locally applied in the DR or mPFC during the second 8-OH-DPAT administration. One-way ANOVA revealed a significant effect of the WAY-100635 application on peak ratios for the effects of 8-OH-DPAT in both regions ( p Ͻ 0.03 in DR; p Ͻ 0.001 in mPFC). Post-hoc t test revealed the existence of a significantly lower reduction of the 5-HT release in DR or mPFC after the application of WAY-100635 in either area, although the attenuation of the effect was smaller when WAY-100635 was locally applied in the mPFC (Fig. 8) .
To examine the extent of the diffusion of the local application of WAY-100635 by reverse dialysis, we performed an in vivo autoradiographic study in which 100 nM [ 3 H]WAY-100635 was perfused together with cold 100 M WAY-100635 in the DR. This area was chosen because of the concentration of 5-HT 1A receptors in a small area of tissue. Rats were killed after 80 min of perfusion, sections were cut at different rostrocaudal levels of the DR, and the radioactivity in each section was counted by image analysis (see Materials and Methods). Figure 9 shows the distribution of the tritium label at different rostrocaudal levels in the DR (n ϭ 4). In the four rats examined, the [ 3 H]WAY-100635 binding was confined within midbrain sections differing 1.2 Ϯ 0.1 mm in their AP coordinate (e.g., Ϯ 0.6 mm on average from the section containing the maximal labeling). Autoradiographic examination of other areas rich in 5-HT 1A receptors, such as hippocampus or frontal cortex did not reveal any labeling above background in any of the four rats (data not shown).
Local administration of 8-OH-DPAT in mPFC
In a second set of microdialysis experiments, we applied 8-OH-DPAT by reverse dialysis into the mPFC and we examined its effects on 5-HT release in this area and the DR. Baseline 5-HT values in dialysates from DR, mPFC, and lateral PFC were 54 Ϯ 4 (n ϭ 25), 15 Ϯ 1 (n ϭ 17), and 12 Ϯ 1 fmol/fraction (n ϭ 7), respectively. The application of 8-OH-DPAT induced a sustained reduction of 5-HT release in medial prefrontal cortex that was maximal at the end of the perfusion period (ϳ50% reduction) ( p Ͻ 0.0001 vs controls, significant effect of time and of the time ϫ treatment interaction; two-way repeated measures ANOVA) (Fig. 10) . A similar reduction was noted when 8-OH- shown by horizontal bars) increased the 5-HT release in the DR ( filled circles; n ϭ 4). Control rats (open circles; n ϭ 6) were implanted with electrodes, but no current was passed. B, The electrical stimulation of mPFC using the same conditions than in PSTH experiments (S4, 0.9 Hz, 2 mA, 0.2 msec; first bar) produced a transient elevation of the 5-HT release in DR (see also the effect of S1 in A), whereas the stimulation at S3 conditions (20 Hz, 0.5 mA, 1 msec) produced a sustained increase in 5-HT release for at least 60 min ( filled circles; n ϭ 7). Control rats (open circles; n ϭ 6) were implanted with electrodes, but no current was passed. The local application of MK-801 (300 M; filled triangles; n ϭ 7) by reverse dialysis prevented the increase in 5-HT release induced by the second stimulation conditions. *p Ͻ 0.05 versus controls; ϩ p Ͻ 0.05 versus stimulation (no MK-801) DPAT was applied in lateral prefrontal cortex ( p Ͻ 0.0001 vs controls, significant effects of time and of treatment ϫ time interaction; two-way repeated measures ANOVA). The average values (baseline ϭ 100%) for the 100 and 300 M applications were 65 Ϯ 5 and 50 Ϯ 4 for mPFC and 61 Ϯ 4 and 51 Ϯ 4 for lateral PFC, respectively.
The application of 8-OH-DPAT in mPFC (but not in the lateral prefrontal cortex) was accompanied by a reduction of the 5-HT release in the DR, which was significantly different from controls ( p Ͻ 0.0001, significant treatment ϫ time interaction; two-way repeated measures ANOVA) (Fig. 10) . The average values in the DR during the period of infusion of 100 M 8-OH-DPAT in mPFC were 100 Ϯ 9 for controls (perfusion of aCSF), 77 Ϯ 4 (8-OH-DPAT in mPFC), and 98 Ϯ 3 (8-OH-DPAT in lateral PFC) ( p Ͻ 0.02; one-way ANOVA). The corresponding values for the period of infusion of 300 M 8-OH-DPAT were, respectively, 96 Ϯ 9, 61 Ϯ 5, and 95 Ϯ 5 ( p Ͻ 0.01, one-way ANOVA). Likewise, the single point application of 8-OH-DPAT (100 M, 200 nl delivered in 1 min) at the coordinate used for mPFC stimulations significantly reduced the firing rate of 5-HT neurons in the DR ( p Ͻ 0.01; paired Student's t test; n ϭ 13) (Fig. 11) . In seven rats, we infused a second dose of 8-OH-DPAT, which reduced the firing rate of 5-HT neurons in the DR further ( p Ͻ 0.01, paired Student's t-test; n ϭ 7).
DISCUSSION
Two main findings derive from the present study. First, projection neurons in the mPFC control the activity of DR 5-HT neurons in a complex manner. Consistent with previous observations, we identified by antidromic activation a substantial number of mPFC neurons projecting monosynaptically to 5-HT neurons (Hajós et al., 1998) . Secondly, postsynaptic 5-HT 1A receptors in mPFC, possibly located in pyramidal neurons projecting to the DR, exert a distal feedback control of serotonergic activity.
Dual control of 5-HT neurons by mPFC afferents
The stimulation of the mPFC mainly inhibited 5-HT neuronal activity, as previously reported (Hajós et al., 1998) . In some instances, this was accompanied by subthreshold (5-10%) activations, whereas 17% of neurons were clearly activated by mPFC stimulation. The abundance of inhibitions was inconsistent with the excitatory nature of projection (pyramidal) neurons in mPFC. We therefore reasoned that the excitation of some 5-HT neurons could increase 5-HT release in the DR, which, acting on 5-HT 1A autoreceptors, would inhibit the same or other 5-HT neurons. This mechanism, assigning an important physiological role to raphe 5-HT 1A autoreceptors, is supported by the following observations. First, mPFC stimulation increased the 5-HT release in the DR at several stimulation conditions, including the one eliciting 5-HT neuronal inhibition. Second, the proportion of inhibi- B and E show the corresponding spike trains of the same neurons before and 2 min after S3 stimulation. During the second minute of the stimulation, the firing rate of 5-HT neurons in pCPA-treated rats was already significantly increased versus basal (1.1 Ϯ 0.2 vs 0.6 Ϯ 0.2 spikes/sec; p Ͻ 0.02). However, the maximal effect of the stimulation was noted later. C and F are bar graphs with the mean Ϯ SEM values of firing rate before and after (4th minute) S3 stimulation (n ϭ 12 controls and 7 pCPA-treated rats). *p Ͻ 0.02 versus baseline.
tions encountered was dramatically reduced in pCPA-pretreated rats, which strongly supports the involvement of 5-HT in the mPFC-triggered inhibitions. Third, these were antagonized by the selective 5-HT 1A receptor antagonist WAY-100635.
A previous report found that neither pCPA nor WAY-100635 reversed the mPFC-induced inhibitions in the DR, concluding that they were independent of 5-HT 1A receptor activation (Hajós et al., 1998) . Two reasons may account for this discrepancy. First, only high doses of pCPA, such as that used herein completely suppress serotonergic function (Chaput et al., 1990) . Second, the dose of WAY-100635 used by Hajós et al. (1998) (100 g/kg, i.v.) may inhibit 5-HT neuronal activity (Martin et al., 1999) . In our hands, an intravenous dose of 5-10 g/kg was sufficient to reverse the inhibitory effects of 5-HT 1A receptor activation on 5-HT cell firing (Casanovas et al., 2000) (L. Romero, P. Celada, and F. Artigas, unpublished observations).
In addition to 5-HT 1A autoreceptors, we present evidence that GABA A receptors also participate in the inhibitory effects of mPFC on serotonergic activity, because inhibitions were also reversed by picrotoxinin. The DR and adjacent periaqueductal gray matter (PAG) contain a large density of GABAergic elements (Nanopoulos et al., 1982; Belin et al., 1983; Abellán et al., 2000) and GABA suppresses the activity of 5-HT neurons (Gallager and Aghajanian, 1976) . Given the existing anatomical and functional relationships between the mPFC, the DR, and the PAG (Thierry et al., 1983; Takagishi et al., 1991; Jolas and Aghajanian, 1997 ) mPFC afferents to the DR or PAG could inhibit the activity of 5-HT neurons through the activation of local GABAergic inputs (Fig. 12) .
Previous in vitro evidence indicates that ionotropic glutamate receptors are involved in the excitatory control of 5-HT neurons (Pan and Williams, 1989) , but no evidence was available that this occurred in vivo. Moreover, the anatomical source of this excitatory input was unknown. Our observations suggest that mPFC afferents control 5-HT neuron activity in vivo through AM-PA-KA and NMDA receptors because NBQX and MK-801 antagonized the orthodromic excitations produced by mPFC stimulation (we used 5-HT-depleted rats to increase the proportion of excitations). These observations parallel the effects of glutamatergic agonists on 5-HT release in the DR (Tao and Auerbach, 1996; Tao et al., 1997) . Likewise, MK-801 pretreatment prevented the increase in DR 5-HT release produced by the mPFC stimulation, which supports that this was caused by an increased glutamatergic input. Interestingly, the higher stimulation frequency used induced a persistent elevation of the 5-HT release, which was accompanied by an increased firing rate. Given the involvement of NMDA receptors in long-term potentiation (Malenka and Nicoll, 1999) , the present results suggest that endogenous glutamate from stimulated mPFC afferents, acting on NMDA receptors, would induce a sustained facilitation of serotonergic activity.
Control of serotonergic activity by 5-HT 1A receptors in mPFC
The inhibition of 5-HT synthesis and release elicited by the systemic administration of selective 5-HT 1A agonists was attributed to the exclusive activation of raphe 5-HT 1A autoreceptors (Hjorth et al., 1987; Hutson et al., 1989) mainly because the activation of 5-HT 1A receptors hyperpolarized 5-HT neurons and reduced cell firing (Aghajanian and Lakoski, 1984; Sprouse and Aghajanian, 1987) . Consistently, the application of direct or indirect 5-HT 1A receptor agonists in the raphe nuclei decreased 5-HT synthesis and release in forebrain (Hutson et al., 1989; Adell and Artigas, 1991; Invernizzi et al., 1991; Adell et al., 1993) .
The present results indicate that postsynaptic 5-HT 1A receptors in mPFC, possibly on pyramidal neurons projecting to the DR, also control 5-HT neuron activity and 5-HT release. First, the local application of 8-OH-DPAT in mPFC reduced the firing rate of DR 5-HT neurons. Diffusion to the DR is unlikely to play a significant role because of the limited diffusion of the small volume (200 nl) used in recording experiments (Myers, 1971) . Second, the application of 8-OH-DPAT in mPFC, but not in lateral prefrontal cortex, reduced the 5-HT release in the DR. The lateral prefrontal cortex contains 5-HT 1A receptors (Pompeiano et al., 1992) but lacks projections to the DR (Peyron et al., 1998) . This characteristic facilitated the assessment of the specificity of the changes observed in the DR when 8-OH-DPAT was applied in mPFC.
The reduction of 5-HT release in mPFC by local 8-OH-DPAT application agrees with previous data (Casanovas et al., 1999) . However, 8-OH-DPAT unexpectedly reduced 5-HT release in lateral prefrontal cortex. Given the apparent absence of terminal 5-HT 1A receptors (Kia et al., 1996) , a tentative explanation for this finding is that postsynaptic 5-HT 1A receptors may additionally control the 5-HT release by local changes in glutamatergic transmission. Hence, the 5-HT 2A and 5-HT 2C receptor agonist DOI, locally applied in mPFC, increased 5-HT release through a 5-HT 2A -and AMPA-KA-dependent mechanism (Martin-Ruiz et al., 2001) . Because of the opposite effects of 5-HT 1A and 5-HT 2A receptor activation on pyramidal neuron excitability (Araneda and Andrade, 1991) 8-OH-DPAT might have effects opposed to those of DOI on 5-HT release.
Consistent with the well established role of DR 5-HT 1A autoreceptors in the control of 5-HT release, the application of WAY-100635 in the DR antagonized the reduction in 5-HT release elicited by systemic 8-OH-DPAT administration. The effect of WAY-100635 was partial, in agreement with its limited diffusion within the DR, as exemplified by [
3 H]WAY-100635. Likewise, the application of WAY-100635 in mPFC also antagonized the effects of systemic 8-OH-DPAT administration on 5-HT release. This effect is most likely attributable to the antagonism of the action of 8-OH-DPAT at postsynaptic 5-HT 1A receptors in pyramidal neurons (Pompeiano et al., 1992; Kia et al., 1996) and adds to the above electrophysiological and neurochemical observations indicating that postsynaptic 5-HT 1A receptors in mPFC control serotonergic activity. WAY-100635 antagonized the effect 4) . B and C show, respectively, 10 autoradiograms of midbrain sections containing the DR and the amount of tritium label in each section. In this particular rat, tritium levels above background were found between approximately Ϫ7.6 to Ϫ8.7 mm from bregma. Note that the shape of the tritium label (dark spots in B) follows the track of the dialysis probe (30°inclination) and has a shape different from that of the DR, suggesting that not all 5-HT 1A receptors within the DR were labeled by the perfusion of Control animals (open circles) received aCSF for the whole experiment (syringe changes were also performed in this group). The application of 8-OH-DPAT in medial prefrontal cortex ( filled circles) significantly reduced the 5-HT release in this area and the DR. In contrast, the perfusion of 8-OH-DPAT in the lateral prefrontal cortex ( filled triangles), an area devoid of neurons projecting to the DR reduced locally the 5-HT release but not in the DR. Data are from seven or eight rats per group.
of systemic 8-OH-DPAT more when applied in the DR than in mPFC, possibly because of the key role of DR 5-HT 1A autoreceptors, but also to the fact that unilateral applications in the mPFC affected half of the putative afferents to the DR (Peyron et al., 1998) . Moreover, not all 5-HT neurons may be controlled by mPFC afferents. Given the marked control of 5-HT function by 5-HT 1A receptors, a potential confounding factor in the present microdialysis experiments could be the use of citalopram in the perfusion fluid. However, 1 M citalopram inhibits partially 5-HT reuptake (Hervás et al., 2000) in a small tissue area surrounding the probe, causing little activation of 5-HT 1A autoreceptors in the DR (Tao et al., 2000) . Higher concentrations (typically Ͼ10 M) are required to significantly activate 5-HT 1A receptors and reduce 5-HT release (Tao et al., 2000) . Consistently, 1 M citalopram did not interfere with the local or systemic actions of 5-HT 1A receptor ligands on 5-HT release in midbrain or forebrain (Casanovas et al., 1997 (Casanovas et al., , 1999 Adell and Artigas, 1998) . On the other hand, citalopram was required to mask the in vivo uptake inhibitory properties of 8-OH-DPAT (Adell et al., 1993; Assié and Koek, 1996) , which would confound its effect on 5-HT 1A receptors.
Conclusions
The present results indicate that the activity of DR 5-HT neurons is strongly regulated by the mPFC. Presynaptic and postsynaptic 5-HT 1A receptors, as well as GABA A and glutamate ionotropic receptors are involved in this control (Fig. 12) . In particular, 5-HT 1A autoreceptors in the DR may play a pivotal role in the physiological control of ascending 5-HT pathways, attenuating excessive activation of 5-HT neurons by excitatory afferents from the mPFC. A corollary of the present observations is that mPFC afferents may differentially drive the activity of 5-HT neurons projecting to different forebrain structures, depending on whether these cells are activated or inhibited (indirectly) by mPFC afferents. Likewise, postsynaptic 5-HT 1A receptors in mPFC exert a distal feedback control of serotonergic activity through the modulation of descending excitatory afferents to the DR. Given the involvement of the serotonergic system in mood control, perception and cognition, the reciprocal interactions between the mPFC and the DR may play an important role in the pathophysiology and treatment of severe psychiatric illnesses, including depression and schizophrenia. (Table 1) and by the reversal of the inhibitions induced by 5-HT 1A receptor blockade with WAY-100635. Additionally, GABAergic inputs may also occur via a serotonergic control of GABA interneurons (Liu et al., 2000) . The firing activity of 5-HT neurons and the release of 5-HT in midbrain and forebrain are dependent on the activation of 5-HT 1A autoreceptors in the DR. However, the activation by 8-OH-DPAT of postsynaptic 5-HT 1A receptors on cortical pyramidal neurons also reduces 5-HT cell firing in the DR and 5-HT release in the DR and mPFC, likely through the inhibition of the activity of excitatory inputs from the mPFC to the DR. Thus, pyramidal 5-HT 1A receptors in mPFC are a second population of 5-HT 1A receptors controlling serotonergic activity.
